| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| iopamidol 612 mg (iodine 300 mg)/mL injection, 50 mL vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| glucose 5% (50 g/L) + sodium chloride 0.45% (4.5 g/L) injection, bag |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| clindamycin 600 mg / 4 mL injection, 4 mL vial (medicinal product unit of use) |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| topotecan 1 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| edetate disodium 3 g/100 mL + sodium ascorbate 15 g/100 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| edetate disodium 3 g + sodium ascorbate 5 g injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| edetate disodium 3 g injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| edetate disodium 3 g + sodium ascorbate 15 g injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| ixekizumab 80 mg / 1 mL injection, 1 mL syringe (medicinal product unit of use) |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| potassium chloride 1.49 g (potassium 20 mmol)/L + glucose 5% (50 g/L) + sodium chloride 0.45% (4.5 g/L) injection, bag |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| potassium chloride 1.49 g (potassium 20 mmol)/L + glucose 5% (50 g/L) + sodium chloride 0.9% (9 g/L) injection, bag |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| potassium chloride 2.98 g (potassium 40 mmol)/L + sodium chloride 0.9% (9 g/L) injection, bag |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| A/Michigan/45/2015 (H1N1)pdm09-like virus 60 microgram + A/Singapore/INFIMH-16-0019/2016 (H3N2)-like virus 60 microgram + B/Phuket/3073/2013-like virus 60 microgram injection, 0.5 mL syringe (medicinal product unit of use) |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
| meningococcal B bivalent vaccine injection, 0.5 mL syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| iron (as ferric derisomaltose) 500 mg/5 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| iron (as ferric derisomaltose) 200 mg/2 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| iron (as ferric derisomaltose) 100 mg/mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| iron (as ferric derisomaltose) 1 g/10 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| rocuronium bromide 25 mg/2.5 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| nandrolone decanoate 50 mg/mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| dupilumab 300 mg/2 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| bezlotoxumab 1 g / 40 mL injection, 40 mL vial (medicinal product unit of use) |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| avelumab 200 mg/10 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| emicizumab 60 mg/0.4 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| emicizumab 30 mg/mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| emicizumab 105 mg/0.7 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| emicizumab 150 mg/mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| follitropin delta 12 microgram/0.36 mL injection, pen device |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| follitropin delta 36 microgram/1.08 mL injection, pen device |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| follitropin delta 72 microgram/2.16 mL injection, pen device |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| follitropin delta 72 microgram/2.16 mL injection, cartridge |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| follitropin delta 36 microgram/1.08 mL injection, cartridge |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| follitropin delta 12 microgram/0.36 mL injection, cartridge |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| carbetocin 100 microgram/mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Synvisc-One 8 mg/mL injection, 6 mL syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| hylan G-F 20 8 mg / 1 mL injection, 6 mL syringe (medicinal product unit of use) |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| influenza quadrivalent adult vaccine 2018 injection, 0.5 mL syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| influenza quadrivalent child vaccine 2018 injection, 0.25 mL syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| adalimumab 80 mg/0.8 mL injection, pen device |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| adalimumab 20 mg/0.2 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| influenza trivalent geriatric vaccine 2018 injection, 0.5 mL syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| adalimumab 80 mg/0.8 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| human papillomavirus 9 valent vaccine injection, 0.5 mL vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| human papillomavirus 9 valent vaccine injection, 0.5 mL syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| influenza trivalent adjuvanted geriatric vaccine 2018 injection, 0.5 mL syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| olive oil 160 g/L + soya oil 40 g/L injection, bottle |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| olive oil 40 g/250 mL + soya oil 10 g/250 mL injection, bottle |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| olive oil 16 g/100 mL + soya oil 4 g/100 mL injection, bottle |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| olive oil 80 g/500 mL + soya oil 20 g/500 mL injection, bottle |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| ibuprofen 10 mg/2 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| American house dust mite extract 10 IR/mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| European house dust mite extract (Dermatophagoides pteronyssinus) 10 IR / 1 mL injection, 5 mL vial (medicinal product unit of use) |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Cynodon dactylon pollen extract 10 IR/mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Plantago lanceolata pollen extract 10 IC/mL injection, 5 mL vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Lolium perenne pollen extract 10 IR/mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Olea europaea pollen extract 10 IR/mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Dactylis glomerata pollen extract 3.333 IR/mL + Lolium perenne pollen extract 3.333 IR/mL + Phleum pratense pollen extract 3.333 IR/mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| glucose 5% (12.5 mg/250 mL) injection, bag |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
| tocilizumab 162 mg/0.9 mL injection, pen device |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| articaine hydrochloride 4% (88 mg/2.2 mL) + adrenaline (epinephrine) 1 in 200 000 (11 microgram/2.2 mL) injection, cartridge |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| lincomycin 600 mg/2 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| lincomycin 300 mg/mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Durolane (hyaluronic acid 20 mg / 1 mL) injection, 3 mL syringe (trade product unit of use) |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| hyaluronic acid 20 mg/mL injection, 3 mL syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| adrenaline (epinephrine) 300 microgram/0.3 mL injection, pen device |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| adrenaline (epinephrine) 150 microgram/0.3 mL injection, pen device |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| dulaglutide 1.5 mg / 0.5 mL injection, 0.5 mL syringe (medicinal product unit of use) |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| nusinersen 12 mg/5 mL injection, vial |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
| epirubicin hydrochloride 150 mg/75 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Agrostis tenuis pollen extract 0.833 IR/mL + Cynodon dactylon pollen extract 0.833 IR/mL + Bromus inermis pollen extract 0.833 IR/mL + Dactylis glomerata pollen extract 0.833 IR/mL + Festuca elatior pollen extract 0.833 IR/mL + Poa pratensis pollen extract 0.833 IR/mL + Arrhenatherum elatius pollen extract 0.833 IR/mL + Lolium perenne pollen extract 0.833 IR/mL + Anthoxanthum odoratum pollen extract 0.833 IR/mL + Phleum pratense pollen extract 0.833 IR/mL + Avena fatua pollen extract 0.833 IR/mL + Holcus lanatus pollen extract 0.833 IR/mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| adrenaline (epinephrine) 150 microgram/0.15 mL injection, pen device |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Amgevita 20 mg/0.4 mL injection, 0.4 mL syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Amgevita Sureclick 40 mg/0.8 mL injection, 0.8 mL pen device |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Amgevita 40 mg/0.8 mL injection, 0.8 mL syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Hadlima Pushtouch Auto-Injector 40 mg/0.8 mL injection, 0.8 mL pen device |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Hadlima 40 mg/0.8 mL injection, 0.8 mL syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| carfilzomib 10 mg injection, 10 mg vial (medicinal product unit of use) |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Sodium Ascorbate (Biological Therapies) 15 g/50 mL injection, 50 mL vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| sodium ascorbate 15 g/50 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Angevour 10 microgram/0.4 mL injection, 0.4 mL syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Angevour with Automatic Needle Guard 30 microgram/0.3 mL injection, 0.3 mL syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Angevour with Automatic Needle Guard 15 microgram/0.38 mL injection, 0.38 mL syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Angevour with Automatic Needle Guard 50 microgram/0.5 mL injection, 0.5 mL syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Angevour with Automatic Needle Guard 200 microgram/0.4 mL injection, 0.4 mL syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Angevour with Automatic Needle Guard 300 microgram/0.6 mL injection, 0.6 mL syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Angevour with Automatic Needle Guard 500 microgram/mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| benzylpenicillin 6 g injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Sodium Bicarbonate (Phebra) 8.4% (8.4 g/100 mL) injection, 100 mL vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Alustal Bermuda Grass Extract 1 IR/mL injection, 5 mL vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Alustal Bermuda Grass Extract 10 IR/mL injection, 5 mL vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Cynodon dactylon pollen extract 1 IR/mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Alustal Bermuda Grass Extract 0.1 IR/mL injection, 5 mL vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Cynodon dactylon pollen extract 0.1 IR/mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| American house dust mite extract 1 IR/mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Alustal American Dust Mite Extract 1 IR/mL injection, 5 mL vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Alustal American Dust Mite Extract 10 IR/mL injection, 5 mL vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| American house dust mite extract 0.1 IR/mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Alustal American Dust Mite Extract 0.1 IR/mL injection, 5 mL vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Alustal European Dust Mite Extract 10 IR/mL injection, 5 mL vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Alustal Rye Grass Extract 1 IR/mL injection, 5 mL vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Alustal Olive Tree Extract 1 IR/mL injection, 5 mL vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|